{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:59:06Z","timestamp":1792511946325,"version":"4.5.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Intravenous thrombolysis (IVT) is a standard procedure for the treatment of patients with acute ischemic stroke (AIS). Improving the therapeutic efficacy of IVT is an important task for neurologists. The aim of this study was to evaluate the efficacy and safety of early low-dose tirofiban treatment in AIS patients with early neurological deterioration (END) after IVT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this prospective and randomized pilot study, 73 AIS patients with END were recruited from a local hospital in China. Of these, 14 patients were treated with regular antiplatelet agents (aspirin plus clopidogrel) and 59 patients were treated with tirofiban within 24 h of IVT, followed by regular antiplatelet therapy. Neurological deficits and functional recovery were assessed with NIHSS and modified Rankin Scale (mRS) at 7 and 90 days. During the 90-day follow-up period, both hemorrhagic (e.g., intracerebral hemorrhage) and non-hemorrhagic (e.g., pneumonia) events were recorded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Treatment with tirofiban compared with regular antiplatelet therapy: (1) improved functional recovery of AIS patients to mRS (\u22642) at both 7 and 90 days (odds ratios [ORs], 1.37 and 1.64; 95% confidence interval [CI], 1.16\u20131.61 and 1.26\u20132.12; <jats:italic>P<\/jats:italic> = 0.008 and &amp;lt; 0.001, respectively), and (2) reduced NIHSS scores from 11.14 \u00b1 2.38 to 5.95 \u00b1 3.48 at day 7 (<jats:italic>P<\/jats:italic> &amp;lt; 0.001) and from 8.14 \u00b1 2.74 to 4.08 \u00b1 3.50 at day 90 (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). Tirofiban treatment did not increase the risk of hemorrhagic complications. Multivariate regression analysis showed that tirofiban treatment independently predicted a favorable functional outcome (<jats:italic>P<\/jats:italic> \u2264 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Early treatment with low-dose tirofiban in AIS patients with neurologic deterioration after IVT potentially improved functional recovery and attenuated neurologic deficits as early as 7 days and did not increase the risk of various hemorrhagic complications. However, the therapeutic efficacy of tirofiban treatment in END patients needs to be determined by future randomized clinical trials with a large study population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:ext-link>http:\/\/www.chictr.org.cn\/<\/jats:ext-link>, Identifier ChiCTR2200058513.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.982684","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T07:18:35Z","timestamp":1664867915000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Prospective pilot study of tirofiban in progressive stroke after intravenous thrombolysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1474-4422(18)30500-3","article-title":"Stroke in China: advances and challenges in epidemiology, prevention, and management","volume":"18","author":"Wu","year":"2019","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","author":"Gbd","year":"2021","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1161\/STR.0000000000000074","article-title":"2015 American Heart Association\/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"46","author":"Powers","year":"2015","journal-title":"Stroke."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0140-6736(18)31874-9","article-title":"Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke","volume":"392","author":"Zerna","year":"2018","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00415-017-8490-3","article-title":"Revisiting 'progressive stroke': incidence, predictors, pathophysiology, and management of unexplained early neurological deterioration following acute ischemic stroke","volume":"265","author":"Seners","year":"2018","journal-title":"J Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/jnnp-2014-308327","article-title":"Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications","volume":"86","author":"Seners","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/CIRCRESAHA.112.300570","article-title":"Integrin alphaIIbbeta3: from discovery to efficacious therapeutic target","volume":"112","author":"Bledzka","year":"2013","journal-title":"Circ Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1161\/STROKEAHA.119.026240","article-title":"Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis","volume":"50","author":"Wu","year":"2019","journal-title":"Stroke."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.044","article-title":"Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke","volume":"28","author":"Liu","year":"2019","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1752-8062.2011.00347.x","article-title":"Recommendations for planning pilot studies in clinical and translational research","volume":"4","author":"Moore","year":"2011","journal-title":"Clin Transl Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/STR.0000000000000086","article-title":"Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"47","author":"Demaerschalk","year":"2016","journal-title":"Stroke."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke."},{"key":"B13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/svn-2020-000378","article-title":"Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases","volume":"5","author":"Liu","year":"2020","journal-title":"Stroke Vasc Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1161\/01.STR.26.8.1365","article-title":"Platelet activation is not involved in acceleration of the coagulation system in acute cardioembolic stroke with nonvalvular atrial fibrillation","volume":"26","author":"Nagao","year":"1995","journal-title":"Stroke."},{"key":"B15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"B16","doi-asserted-by":"publisher","first-page":"785836","DOI":"10.3389\/fneur.2021.785836","article-title":"Efficacy and safety of tirofiban in clinical patients with acute ischemic stroke","volume":"12","author":"Han","year":"2021","journal-title":"Front Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1007\/s12035-018-1391-3","article-title":"Contribution of serum lipid profiles to outcome after endovascular thrombectomy for anterior circulation ischemic stroke","volume":"56","author":"Pikija","year":"2019","journal-title":"Mol Neurobiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12883-021-02387-2","article-title":"Association between low-density cholesterol change and outcomes in acute ischemic stroke patients who underwent reperfusion therapy","volume":"21","author":"Cui","year":"2021","journal-title":"BMC Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nature06797","article-title":"Triggers, targets and treatments for thrombosis","volume":"451","author":"Mackman","year":"2008","journal-title":"Nature."},{"key":"B20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00001721-199603000-00011","article-title":"Platelet size: measurement, physiology and vascular disease","volume":"7","author":"Bath","year":"1996","journal-title":"Blood Coagul Fibrinolysis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3389\/fneur.2019.01274","article-title":"Mean platelet volume-to-lymphocyte ratio predicts poor functional outcomes among ischemic stroke patients treated with intravenous thrombolysis","volume":"10","author":"Chen","year":"2019","journal-title":"Front Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"105718","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105718","article-title":"Mean platelet volume is a prognostic marker in acute ischemic stroke patients treated with intravenous thrombolysis","volume":"30","author":"Dourado Sotero","year":"2021","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1161\/STROKEAHA.116.015414","article-title":"Is unexplained early neurological deterioration after intravenous thrombolysis associated with thrombus extension?","volume":"48","author":"Seners","year":"2017","journal-title":"Stroke."},{"key":"B24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1161\/01.STR.32.3.661","article-title":"Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial","volume":"32","author":"Grotta","year":"2001","journal-title":"Stroke."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1161\/STROKEAHA.114.005426","article-title":"Unexplained early neurological deterioration after intravenous thrombolysis: incidence, predictors, and associated factors","volume":"45","author":"Seners","year":"2014","journal-title":"Stroke."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1067","DOI":"10.1212\/WNL.0000000000006168","article-title":"Dual antiplatelet therapy pretreatment in IV thrombolysis for acute ischemic stroke","volume":"91","author":"Tsivgoulis","year":"2018","journal-title":"Neurology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1161\/STROKEAHA.116.014413","article-title":"Safety and preliminary efficacy of early tirofiban treatment after alteplase in acute ischemic stroke patients","volume":"47","author":"Li","year":"2016","journal-title":"Stroke."},{"key":"B28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/00001721-199210000-00028","article-title":"Intravascular platelet activation depends on the degree of stenosis of major cranial arteries in patients with atherosclerosis","volume":"3","author":"Akopov","year":"1992","journal-title":"Blood Coagul Fibrinolysis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/01.ATV.17.4.646","article-title":"Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis","volume":"17","author":"Holme","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1212\/01.wnl.0000208220.04165.05","article-title":"Levels and value of platelet activity in patients with severe internal carotid artery stenosis","volume":"66","author":"Yip","year":"2006","journal-title":"Neurology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1160\/TH09-03-0192","article-title":"Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis","volume":"102","author":"Jennings","year":"2009","journal-title":"Thromb Haemost."},{"key":"B32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/STROKEAHA.106.476648","article-title":"Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)","volume":"39","author":"Adams","year":"2008","journal-title":"Stroke."},{"key":"B33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/BTT.S1374","article-title":"Abciximab: a reappraisal of its use in coronary care","volume":"2","author":"Valgimigli","year":"2008","journal-title":"Biologics."},{"key":"B34","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000047726","article-title":"Bleeding risk of tirofiban, a nonpeptide GPIIb\/IIIa platelet receptor antagonist in progressive stroke: an open pilot study","volume":"12","author":"Junghans","year":"2001","journal-title":"Cerebrovasc Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.58.3.474","article-title":"Ischemic brain tissue salvaged from infarction by the GP IIb\/IIIa platelet antagonist tirofiban","volume":"58","author":"Junghans","year":"2002","journal-title":"Neurology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1161\/01.CIR.0000070544.15890.0E","article-title":"Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb\/IIIa receptor antagonist","volume":"107","author":"Junghans","year":"2003","journal-title":"Circulation."},{"key":"B37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1161\/01.STR.0000117094.41638.EE","article-title":"Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion","volume":"35","author":"Straub","year":"2004","journal-title":"Stroke."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1161\/STROKEAHA.110.599662","article-title":"Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial","volume":"42","author":"Siebler","year":"2011","journal-title":"Stroke."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1161\/STROKEAHA.117.019193","article-title":"Low-dose tirofiban improves functional outcome in acute ischemic stroke patients treated with endovascular thrombectomy","volume":"48","author":"Zhao","year":"2017","journal-title":"Stroke."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3389\/fneur.2019.01100","article-title":"Safety and efficacy of tirofiban combined with mechanical thrombectomy depend on ischemic stroke etiology","volume":"10","author":"Sun","year":"2019","journal-title":"Front Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1161\/STROKEAHA.120.029994","article-title":"Intraarterial vs. intravenous tirofiban as an adjunct to endovascular thrombectomy for acute ischemic stroke","volume":"51","author":"Yang","year":"2020","journal-title":"Stroke."},{"key":"B42","doi-asserted-by":"publisher","first-page":"688019","DOI":"10.3389\/fneur.2021.688019","article-title":"Can tirofiban improve the outcome of patients with acute ischemic stroke: a propensity score matching analysis","volume":"12","author":"Cai","year":"2021","journal-title":"Front Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"630301","DOI":"10.3389\/fneur.2021.630301","article-title":"Safety and efficacy of tirofiban for acute ischemic stroke patients with large artery atherosclerosis stroke etiology undergoing endovascular therapy","volume":"12","author":"Huo","year":"2021","journal-title":"Front Neurol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"666919","DOI":"10.3389\/fneur.2021.666919","article-title":"Safety and efficacy of low-dose tirofiban combined with intravenous thrombolysis and mechanical thrombectomy in acute ischemic stroke: a matched-control analysis from a nationwide registry","volume":"12","author":"Ma","year":"2021","journal-title":"Front Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1161\/STROKEAHA.111.000502","article-title":"Endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome","volume":"44","author":"Kellert","year":"2013","journal-title":"Stroke."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.982684\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T07:18:37Z","timestamp":1664867917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.982684\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":45,"alternative-id":["10.3389\/fneur.2022.982684"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.982684","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"article-number":"982684"}}